Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialKalifa Bojang, Tom Doherty, Paul Milligan et al.|The Lancet|2001Cited by 528
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineDaniel E. Neafsey, Dyann F. Wirth, Carsten Russ et al.|New England Journal of Medicine|2015Cited by 451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the GambiaMark Thursz, Adrian V. S. Hill, Dominic Kwiatkowski et al.|New England Journal of Medicine|1995Cited by 439
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Heterozygote advantage for HLA class-II type in hepatitis B virus infectionMark Thursz, Adrian V. S. Hill, Howard C. Thomas et al.|Nature Genetics|1997Cited by 319